|
1
|
Di Paola R, Menzaghi C, De Filippis V,
Corda D and Di Cerbo A: Cyclooxygenase-dependent thyroid cell
proliferation induced by immunoglobulins from patients with Graves’
disease. J Clin Endocrinol Metab. 82:670–673. 1997.PubMed/NCBI
|
|
2
|
Chistiakov DA: Thyroid-stimulating hormone
receptor and its role in Graves’ disease. Mol Genet Metab.
80:377–388. 2003.
|
|
3
|
Weetman AP: Graves’ disease. N Engl J Med.
343:1236–1248. 2000.
|
|
4
|
Farid NR and Balazs C: The genetics of
thyroid associated ophthalmopathy. Thyroid. 8:407–409. 1998.
View Article : Google Scholar
|
|
5
|
Falgarone G, Heshmati HM, Cohen R and
Reach G: Mechanisms in endocrinology. Role of emotional stress in
the pathophysiology of Graves’ disease. Eur J Endocrinol.
168:R13–R18. 2012.PubMed/NCBI
|
|
6
|
Jacobson EM and Tomer Y: The CD40, CTLA-4,
thyroglobulin, TSH receptor, and PTPN22 gene quintet and its
contribution to thyroid autoimmunity: back to the future. J
Autoimmun. 28:85–98. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brand OJ, Barrett JC, Simmonds MJ, et al:
Association of the thyroid stimulating hormone receptor gene (TSHR)
with Graves’ disease. Hum Mol Genet. 18:1704–1713. 2009.
|
|
8
|
Jia HY, Zhang ZG, Gu XJ, et al:
Association between interleukin 21 and Graves’ disease. Genet Mol
Res. 10:3338–3346. 2011.
|
|
9
|
Simmonds MJ, Howson JM, Heward JM, et al:
A novel and major association of HLA-C in Graves’ disease that
eclipses the classical HLA-DRB1 effect. Hum Mol Genet.
16:2149–2153. 2007.PubMed/NCBI
|
|
10
|
Simmonds MJ, Howson JM, Heward JM, et al:
Regression mapping of association between the human leukocyte
antigen region and Graves disease. Am J Hum Genet. 76:157–163.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Heward JM, Brand OJ, Barrett JC, et al:
Association of PTPN22 haplotypes with Graves’ disease. J Clin
Endocrinol Metab. 92:685–690. 2007.
|
|
12
|
Vaidya B, Imrie H, Perros P, et al: The
cytotoxic T lymphocyte antigen-4 is a major Graves’ disease locus.
Hum Mol Genet. 8:1195–1199. 1999.PubMed/NCBI
|
|
13
|
Ban Y, Tozaki T, Taniyama M, Tomita M and
Ban Y: Association of a CTLA-4 3′ untranslated region (CT60) single
nucleotide polymorphism with autoimmune thyroid disease in the
Japanese population. Autoimmunity. 38:151–153. 2005.
|
|
14
|
Ettinger R, Kuchen S and Lipsky PE:
Interleukin 21 as a target of intervention in autoimmune disease.
Ann Rheum Dis. 67(Suppl 3): iii83–iii86. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Spolski R and Leonard WJ: Interleukin-21:
basic biology and implications for cancer and autoimmunity. Annu
Rev Immunol. 26:57–79. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Habib T, Senadheera S, Weinberg K and
Kaushansky K: The common gamma chain (gamma c) is a required
signaling component of the IL-21 receptor and supports
IL-21-induced cell proliferation via JAK3. Biochemistry.
41:8725–8731. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Caruso R, Fina D, Peluso I, et al: A
functional role for interleukin-21 in promoting the synthesis of
the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells.
Gastroenterology. 132:166–175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jüngel A, Distler JH, Kurowska-Stolarska
M, et al: Expression of interleukin-21 receptor, but not
interleukin-21, in synovial fibroblasts and synovial macrophages of
patients with rheumatoid arthritis. Arthritis Rheum. 50:1468–1476.
2004.
|
|
19
|
Distler JH, Jüngel A, Kowal-Bielecka O, et
al: Expression of interleukin-21 receptor in epidermis from
patients with systemic sclerosis. Arthritis Rheum. 52:856–864.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Davis ID, Skak K, Smyth MJ, et al:
Interleukin-21 signaling: functions in cancer and autoimmunity.
Clin Cancer Res. 13:6926–6932. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Bleakley M and Yee C: IL-21
influences the frequency, phenotype, and affinity of the
antigen-specific CD8 T cell response. J Immunol. 175:2261–2269.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Parrish-Novak J, Dillon SR, Nelson A, et
al: Interleukin 21 and its receptor are involved in NK cell
expansion and regulation of lymphocyte function. Nature. 408:57–63.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zeng R, Spolski R, Finkelstein SE, et al:
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and
function. J Exp Med. 201:139–148. 2005.PubMed/NCBI
|
|
24
|
Ozaki K, Spolski R, Ettinger R, et al:
Regulation of B cell differentiation and plasma cell generation by
IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol.
173:5361–5371. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ettinger R, Sims GP, Fairhurst AM, et al:
IL-21 induces differentiation of human naive and memory B cells
into antibody-secreting plasma cells. J Immunol. 175:7867–7879.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ozaki K, Spolski R, Feng CG, et al: A
critical role for IL-21 in regulating immunoglobulin production.
Science. 298:1630–1634. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sawalha AH, Kaufman KM, Kelly JA, et al:
Genetic association of interleukin-21 polymorphisms with systemic
lupus erythematosus. Ann Rheum Dis. 67:458–461. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li J, Shen W, Kong K and Liu Z:
Interleukin-21 induces T-cell activation and proinflammatory
cytokine secretion in rheumatoid arthritis. Scand J Immunol.
64:515–522. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Coenen MJ and Gregersen PK: Rheumatoid
arthritis: a view of the current genetic landscape. Genes Immun.
10:101–111. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Asano K, Ikegami H, Fujisawa T, et al:
Molecular scanning of interleukin-21 gene and genetic
susceptibility to type 1 diabetes. Hum Immunol. 68:384–391. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang J, Zeng H, Ren M, et al:
Interleukin-21 is associated with disease activity in patients with
Graves’ disease. Endocrine. Nov 28–2013.(Epub ahead of print).
|
|
32
|
Meller J, Jauho A, Hüfner M, Gratz S and
Becker W: Disseminated thyroid autonomy or Graves’ disease:
reevaluation by a second generation TSH receptor antibody assay.
Thyroid. 10:1073–1079. 2000.
|
|
33
|
Liu L, Wu HQ, Wang Q, Zhu YF, et al:
Association between thyroid stimulating hormone receptor gene
intron polymorphisms and autoimmune thyroid disease in a Chinese
Han population. Endocr J. 59:717–723. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Simmonds MJ, Heward JM, Carr-Smith J, et
al: Contribution of single nucleotide polymorphisms within FCRL3
and MAP3K7IP2 to the pathogenesis of Graves’ disease. J Clin
Endocrinol Metab. 91:1056–1061. 2006.PubMed/NCBI
|
|
35
|
Plagnol V, Howson JM, Smyth DJ, et al:
Genome-wide association analysis of autoantibody positivity in type
1 diabetes cases. PLoS Genet. 7:e10022162011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Festen EA, Goyette P, Scott R, et al:
Genetic variants in the region harbouring IL2/IL21 associated with
ulcerative colitis. Gut. 58:799–804. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zeng R, Spolski R, Casas E, et al: The
molecular basis of IL-21-mediated proliferation. Blood.
109:4135–4142. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Konforte D and Paige CJ: Identification of
cellular intermediates and molecular pathways induced by IL-21 in
human B cells. J Immunol. 177:8381–8392. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Coquet JM, Kyparissoudis K, Pellicci DG,
et al: IL-21 is produced by NKT cells and modulates NKT cell
activation and cytokine production. J Immunol. 178:2827–2834. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rahman M, Nara H, Onoda T, et al: Cloning
and characterization of an isoform of interleukin-21. FEBS Lett.
581:4001–4009. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
King C, Ilic A, Koelsch K and Sarvetnick
N: Homeostatic expansion of T cells during immune insufficiency
generates autoimmunity. Cell. 117:265–277. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Monteleone G, Monteleone I, Fina D, et al:
Interleukin-21 enhances T-helper cell type I signaling and
interferon-gamma production in Crohn’s disease. Gastroenterology.
128:687–694. 2005.PubMed/NCBI
|
|
43
|
di Carlo E, de Totero D, Piazza T, Fabbi M
and Ferrini S: Role of IL-21 in immune-regulation and tumor
immunotherapy. Cancer Immunol Immunother. 56:1323–1334.
2007.PubMed/NCBI
|
|
44
|
Ding L, Wang S, Chen GM, et al: A single
nucleotide polymorphism of IL-21 gene is associated with systemic
lupus erythematosus in a Chinese population. Inflammation.
35:1781–1785. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu Y, Helms C, Liao W, et al: A
genome-wide association study of psoriasis and psoriatic arthritis
identifies new disease loci. PLoS Genet. 4:e10000412008. View Article : Google Scholar
|
|
46
|
Leonard WJ and Spolski R: Interleukin-21:
a modulator of lymphoid proliferation, apoptosis and
differentiation. Nat Rev Immunol. 5:688–698. 2005. View Article : Google Scholar : PubMed/NCBI
|
